JPWO2022025069A1 - - Google Patents
Info
- Publication number
- JPWO2022025069A1 JPWO2022025069A1 JP2022539503A JP2022539503A JPWO2022025069A1 JP WO2022025069 A1 JPWO2022025069 A1 JP WO2022025069A1 JP 2022539503 A JP2022539503 A JP 2022539503A JP 2022539503 A JP2022539503 A JP 2022539503A JP WO2022025069 A1 JPWO2022025069 A1 JP WO2022025069A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/61—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Databases & Information Systems (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020127010 | 2020-07-28 | ||
| JP2020127010 | 2020-07-28 | ||
| PCT/JP2021/027776 WO2022025069A1 (ja) | 2020-07-28 | 2021-07-27 | 疾患リスク評価方法、疾患リスク評価装置、及び疾患リスク評価プログラム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022025069A1 true JPWO2022025069A1 (https=) | 2022-02-03 |
| JPWO2022025069A5 JPWO2022025069A5 (https=) | 2022-11-10 |
| JP7170368B2 JP7170368B2 (ja) | 2022-11-14 |
Family
ID=80036648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539503A Active JP7170368B2 (ja) | 2020-07-28 | 2021-07-27 | 疾患リスク評価方法、疾患リスク評価装置、及び疾患リスク評価プログラム |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20230274840A1 (https=) |
| JP (1) | JP7170368B2 (https=) |
| WO (1) | WO2022025069A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115116615A (zh) * | 2022-07-11 | 2022-09-27 | 江苏亚寰软件股份有限公司 | 一种对非酒精性脂肪肝风险的分析预测方法及系统 |
| WO2024097993A1 (en) * | 2022-11-06 | 2024-05-10 | Mayo Foundation For Medical Education And Research | Machine learning-based risk stratification and management of non-alcoholic fatty liver disease |
| KR102616840B1 (ko) | 2023-02-17 | 2023-12-21 | 주식회사 바이오뉴트리온 | 비알코올성 지방간질환 위험성 자가 평가 방법 |
| WO2024172240A1 (ko) * | 2023-02-17 | 2024-08-22 | 주식회사 바이오뉴트리온 | 비알코올성 지방간질환 위험성 자가 평가 방법 |
| WO2025173349A1 (ja) * | 2024-02-16 | 2025-08-21 | Ｎｅｃソリューションイノベータ株式会社 | 疾患発症リスク予測装置、予測マーカセット、予測方法、プログラム、及び記録媒体 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012194170A (ja) * | 2011-03-02 | 2012-10-11 | Nagasaki Univ | ペプチドの検出方法 |
| WO2015019976A1 (ja) * | 2013-08-05 | 2015-02-12 | 第一三共株式会社 | 肝障害のタイプの検査方法 |
| WO2017043617A1 (ja) * | 2015-09-10 | 2017-03-16 | エーディア株式会社 | 肝癌の検査方法 |
| WO2019220833A1 (ja) * | 2018-05-18 | 2019-11-21 | 株式会社島津製作所 | 診断支援システムおよび診断支援装置 |
| WO2020096043A1 (ja) * | 2018-11-09 | 2020-05-14 | 積水メディカル株式会社 | ウィルス性肝癌の検出方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050096530A1 (en) * | 2003-10-29 | 2005-05-05 | Confirma, Inc. | Apparatus and method for customized report viewer |
| US8275442B2 (en) * | 2008-09-25 | 2012-09-25 | Zeltiq Aesthetics, Inc. | Treatment planning systems and methods for body contouring applications |
| WO2014028494A1 (en) * | 2012-08-13 | 2014-02-20 | The Regents Of The University Of California | Detecting and treating liver damage |
| WO2015120064A1 (en) * | 2014-02-04 | 2015-08-13 | Cardioinsight Technologies, Inc. | Integrated analysis of electrophysiological data |
| TW201643760A (zh) * | 2015-04-10 | 2016-12-16 | Social Welfare Organization Saiseikai Imp Gift Foundation Inc Saiseikai Suita Hospital | 判別肝疾病之疾病狀態之方法 |
| WO2018124831A1 (ko) * | 2016-12-30 | 2018-07-05 | 서울대학교 산학협력단 | 대사이상 질환의 질병 위험도를 예측하는 장치 및 방법 |
| WO2019191059A1 (en) * | 2018-03-26 | 2019-10-03 | The General Hospital Corporation | Method for objective, noninvasive staging of diffuse liver disease from ultrasound shear-wave elastography |
| US10978176B2 (en) * | 2018-06-29 | 2021-04-13 | pulseData Inc. | Machine learning systems and methods for predicting risk of renal function decline |
-
2021
- 2021-07-27 WO PCT/JP2021/027776 patent/WO2022025069A1/ja not_active Ceased
- 2021-07-27 US US18/006,873 patent/US20230274840A1/en active Pending
- 2021-07-27 JP JP2022539503A patent/JP7170368B2/ja active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012194170A (ja) * | 2011-03-02 | 2012-10-11 | Nagasaki Univ | ペプチドの検出方法 |
| WO2015019976A1 (ja) * | 2013-08-05 | 2015-02-12 | 第一三共株式会社 | 肝障害のタイプの検査方法 |
| WO2017043617A1 (ja) * | 2015-09-10 | 2017-03-16 | エーディア株式会社 | 肝癌の検査方法 |
| WO2019220833A1 (ja) * | 2018-05-18 | 2019-11-21 | 株式会社島津製作所 | 診断支援システムおよび診断支援装置 |
| WO2020096043A1 (ja) * | 2018-11-09 | 2020-05-14 | 積水メディカル株式会社 | ウィルス性肝癌の検出方法 |
Non-Patent Citations (3)
| Title |
|---|
| ATABAKI-PASDAR, N. ET AL.: "Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and vali", PLOS MEDLINE, vol. 17, no. 6, JPN6021034698, 19 June 2020 (2020-06-19), pages 1 - 27, ISSN: 0004874914 * |
| FIALOKE, S. ET AL.: "Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoh", AMIA ANNUAL SYMPOSIUM PROCEEDINGS ARCHIVE, JPN6021034697, 5 December 2018 (2018-12-05), pages 430 - 439, ISSN: 0004874913 * |
| POYNARD, T. ET AL.: "The diagnostic value of biomarkers (Steato Test) for the prediction of liver steatosis", COMPARATIVE HEPATOLOGY, vol. Vol.4, Article number: 10, JPN6021034696, 23 December 2005 (2005-12-23), pages 1 - 14, ISSN: 0004874912 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7170368B2 (ja) | 2022-11-14 |
| US20230274840A1 (en) | 2023-08-31 |
| WO2022025069A1 (ja) | 2022-02-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220803 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220803 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220803 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220914 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220927 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221004 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221025 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7170368 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |